Clicky

Health

EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for The Use of The Moderna Covid-19 Vaccine in Children (6-11 Years) In the European Union
1200 277 Lauren

Announcement follows CHMP’s previous decision to adopt a positive opinion recommending marketing authorization for Moderna’s COVID-19 vaccine to include adolescents 12 years of age and older. CAMBRIDGE, MA / ACCESSWIRE / February 24, 2022 /…

  • Lauren
  • 0
  • 0

COVID-19 Causing a Cosmetic Surgery Surge
2000 2000 Jessi

Cosmetic Appearance Enhancements Help Reduce Low Self Image and Depression Caused by Pandemic Pressures AREQUIPA, PERU / ACCESSWIRE / February 15, 2022 / If the pandemic has been bringing on the stress of low self-image…

  • Jessi
  • 0
  • 0

Net Medical’s Upper Respiratory Test Identifies COVID, Flu and the Common Cold; More States To Be Added
700 140 Rick

Leaning on two decades of experience connecting providers with the patients who need them, Net Medical’s business is unique and growing. ALBUQUERQUE, NM / ACCESSWIRE / February 16, 2022 / Net Medical Xpress Solutions (OTC…

  • Rick
  • 0
  • 0

Latina-Led Respira Labs Raises $2.8 Million to Revolutionize Respiratory Care for COPD, COVID-19 and Asthma Patients
595 120 George

The funding is a major win for a standout medtech startup and U.S. Latinx startup community; allows the company to grow team, develop clinical trials The medtech startup offers the only wearable device to monitor…

  • George
  • 0
  • 0

COVID-19 and Its Impact on Veterinary Care
500 161 Riley

5 tips to ensure the best care for your pet MISSION, KS / ACCESSWIRE / February 10, 2022 / (Family Features) The COVID-19 pandemic has placed historic pressures on the veterinary field and pet owners…

  • Riley
  • 0
  • 0

Biophytis Received Approval from ANVISA (Brazil) to Give Access to Sarconeos (BIO101) to Hospitalized COVID-19 Patients through an Expanded Access Program
150 150 Lauren

ANVISA (Brazilian Health Authority) approved Biophytis’ Expanded Access Program (EAP) for hospitalized patients with severe COVID-19 and mechanically ventilated in Intensive Care UnitSarconeos (BIO101) treatment will be given to a maximum of 80 patients mechanically…

  • Lauren
  • 0
  • 0

Gemina Labs Announces Completion of Significant Development Step for its SARS-CoV-2 Rapid Test
404 66 Riley

VANCOUVER, BC / ACCESSWIRE / February 3, 2022 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the “Company” or “Gemina“) is pleased to provide an update on its current activities related to the development of its first rapid…

  • Riley
  • 0
  • 0

Relief Reports that its U.S. Collaboration Partner has Announced Receipt of Initial Report of Patient Safety and Survival from Right to Try Use of Aviptadil During Omicron Surge
440 386 Lauren

GENEVA, SWITZERLAND / ACCESSWIRE / January 27, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (“Relief“), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, reported today that the…

  • Lauren
  • 0
  • 0

IAVI and Moderna Launch Trial of HIV Vaccine Antigens Delivered Through mRNA Technology
1200 277 Rick

CAMBRIDGE, MA and NEW YORK, NY / ACCESSWIRE / January 27, 2022 / IAVI, the nonprofit scientific research organization, and biotechnology company Moderna announced today that first doses have been administered in a clinical trial…

  • Rick
  • 0
  • 0

WithHealth Publishes Whitepaper on Strengthening Workplace Safety
1500 267 Jessi

SAN DIEGO, CA / ACCESSWIRE / January 11, 2022 / WithHealth, Inc. (the “Company”), a digital precision care telehealth company for employers and their employees, is pleased to publish its whitepaper on strengthening workplace safety,…

  • Jessi
  • 0
  • 0